Corporate GovernanceMay 11, 2026, 02:16 PM
TDAC Disclosure Controls Not Effective as of Dec 31, 2025
AI Summary
Translational Development Acquisition Corp. (TDAC) filed an amendment to its 10-K, revising its conclusion regarding the effectiveness of its disclosure controls and procedures. The company now states that these controls were not effective as of December 31, 2025. This amendment also incorporates new certifications from the principal executive and financial officers as mandated by Sections 302 and 906 of the Sarbanes-Oxley Act. Despite the ineffectiveness of disclosure controls, management affirmed that internal control over financial reporting remained effective as of the same date.
Key Highlights
- Translational Development Acquisition Corp. revised its conclusion on disclosure controls and procedures.
- Disclosure controls and procedures were determined to be not effective as of December 31, 2025.
- Management concluded that internal control over financial reporting was effective as of December 31, 2025.
- The amendment includes new Section 302 certifications from principal executive and financial officers.
- The amendment includes new Section 906 certifications from principal executive and financial officers.
- No material changes in internal control over financial reporting occurred during the most recent fiscal quarter.
Price Impact
More from TDAC